Page last updated: 2024-10-17

bupropion and Hypokalemia

bupropion has been researched along with Hypokalemia in 1 studies

Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.

Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wilson, B1
Paul, P1
Mehta, S1
Coffey, BJ1

Other Studies

1 other study available for bupropion and Hypokalemia

ArticleYear
Hypokalemia secondary to bupropion sustained release overdose.
    Journal of child and adolescent psychopharmacology, 2013, Volume: 23, Issue:1

    Topics: Adolescent; Antidepressive Agents, Second-Generation; Bupropion; Delayed-Action Preparations; Drug O

2013